Top Diseases Stories


Comment & Analysis »

GlobalData Healthcare

FMT therapy from Rebiotix achieves positive Phase II results for recurrent C. difficile

Clostridium difficile, the most common healthcare-acquired superbug, is estimated to have been responsible for over 29,000 deaths in the US during 2011....

FMT therapy from Rebiotix achieves positive Phase II results for recurrent C. difficile
GlobalData Healthcare

Rethinking future treatment options for sepsis: from immunosuppressive to immunostimulating drugs

Rethinking future treatment options for sepsis: from immunosuppressive to immunostimulating drugs
GBI Research

Hope for sufferers with extremely rare form of liver cancer

Hope for sufferers with extremely rare form of liver cancer
GlobalData Healthcare

AD/PD 2017 conference coverage: Future directions for Alzheimer's drug development

AD/PD 2017 conference coverage: Future directions for Alzheimer's drug development
GlobalData Healthcare

AD/PD conference coverage: How to succeed in late-phase Alzheimer’s research

AD/PD conference coverage: How to succeed in late-phase Alzheimer’s research

Company Releases »

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

SYSTAG Systems Technik
ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

Benefits of Trehalose

Pfanstiehl
Benefits of Trehalose

Automation Systems for Small-Molecule Drug and API Development

SYSTAG Systems Technik Automation Systems for Small-Molecule Drug and API Development

Characterisation Information of Critical Excipients for Sourcing Critical Raw Materials

Pfanstiehl
Characterisation Information of Critical Excipients for Sourcing Critical Raw Materials

Paradigm Shift Regarding API and Formulation Components

Pfanstiehl Paradigm Shift Regarding API and Formulation Components

Diseases Insights »

Companies »